Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial.

Clin Lymphoma Myeloma Leuk · 2021 · PMC8528179 · PMID 34059488

Europe PMC DOI

hedged sentence

0.0830

closest p · 1.7× alpha

0.0830

boldest claim

The sentences

did not reach statistical significancep = 0.083so close (0.05 < p ≤ 0.1)

For OS ( Figure 3 C-E) there was no difference in outcome in the SR or HiR groups, but in the UHiR group the OS for males was 34 months and for females 41 months, although this difference did not reach statistical significance, HR 0.74 (95% CI, 0.52-1.04, p = 0.083).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.